Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017.

• Hiemke C Department of Psychiatry and Psychotherapy, University Medical Center of Mainz, Mainz, Germany.
• Bergemann N Kitzberg Hospitals, Center for Psychosomatic Medicine and Psychotherapy, Bad Mergentheim, Germany.
• Clement HW Department of Child and Adolescent Psychiatry, University of Freiburg, Freiburg, Germany.
• Conca A Servizio Psichiatrico del Comprensorio Sanitario di Bolzano, Bolzano, Italy.
• Deckert J Department of Psychiatry, Psychotherapy and Psychosomatics, University Hospital of Würzburg, Germany.
• Domschke K Department of Psychiatry and Psychotherapy, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
• Eckermann G Psychiatric Hospital, Kaufbeuren, Germany.
• Egberts K Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, Center of Mental Health, University Hospital of Würzburg, Germany.
• Gerlach M Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, Center of Mental Health, University Hospital of Würzburg, Germany.
• Greiner C Federal Institute for Drugs and Medical Devices (BfArM), Bonn, Germany.
• Gründer G Department of Psychiatry, Psychotherapy and Psychosomatics, RWTH Aachen University, Aachen, and JARA - Translational Brain Medicine, Aachen, Germany.
• Haen E Clinical Pharmacology, Department of Psychiatry and Psychotherapy and Department of Pharmacology and Toxicology, University of Regensburg, Regensburg, Germany.
• Havemann-Reinecke U Department of Psychiatry and Psychosomatics, University of Göttingen, Göttingen, Germany.
• Hefner G Psychiatric Hospital, Vitos Klinik, Eichberg, Eltville, Germany.
• Helmer R Center of Epilepsy, Bielefeld, Germany.
• Janssen G Medical Laboratory Stein, Limbach Group, Mönchengladbach, Germany.
• Jaquenoud E Psychiatric Hospital, Königsfelden, Brugg, Aargau, Switzerland.
• Laux G Institute of Psychological Medicine, Haag in Oberbayern, Germany.
• Messer T Danuviuskliniken, Psychiatric Hospital, Pfaffenhofen, Germany.
• Mössner R Department of Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany.
• Müller MJ Psychiatric Hospitals Oberberggruppe, Berlin, Germany.
• Paulzen M Department of Psychiatry, Psychotherapy and Psychosomatics, RWTH Aachen University, Aachen, and JARA - Translational Brain Medicine, Aachen, Germany.
• Pfuhlmann B Psychiatric Hospital Weisser Hirsch, Dresden, Germany.
• Riederer P Department of Psychiatry, Psychotherapy and Psychosomatics, University Hospital of Würzburg, Germany.
• Saria A Experimental Psychiatry Unit, Department of Psychiatry 1, Medical University of Innsbruck, Innsbruck, Austria.
• Schoppek B kbo-Isar-Amper Klinikum München-Ost, Psychiatric Hospital, Munich-Haar, Germany.
• Schoretsanitis G Department of Psychiatry, University of Bern, Bern, Switzerland.
• Schwarz M Department of Laboratory Medicine, Ludwig Maximilian University, Munich, Germany.
• Gracia MS Clinical Pharmacology, Department of Psychiatry and Psychotherapy and Department of Pharmacology and Toxicology, University of Regensburg, Regensburg, Germany.
• Stegmann B Clinical Pharmacology, Department of Psychiatry and Psychotherapy and Department of Pharmacology and Toxicology, University of Regensburg, Regensburg, Germany.
• Steimer W Institute of Clinical Chemistry and Pathobiochemistry, Technical University Munich, Munich, Germany.
• Stingl JC Federal Institute for Drugs and Medical Devices (BfArM), Bonn, Germany.
• Uhr M Max Planck Institute of Psychiatry, Munich, Germany.
• Ulrich S Aristo Pharma GmbH, Berlin, Germany.
• Unterecker S Department of Psychiatry, Psychotherapy and Psychosomatics, University Hospital of Würzburg, Germany.
• Waschgler R Psychiatric Hospital, Feldkirch, Austria.
• Zernig G Experimental Psychiatry Unit, Department of Psychiatry 1, Medical University of Innsbruck, Innsbruck, Austria.
• Zurek G Medical Laboratory Bremen, Bremen, Germany.
• Baumann P Department of Psychiatry, University of Lausanne, Prilly-Lausanne, Switzerland.

Show more…

Drug Monitoring

Guidelines as Topic

Humans

Mental Disorders

Neuropharmacology

Psychopharmacology

Psychotropic Drugs